Core Points - CapsoVision, Inc. has announced the pricing of its initial public offering (IPO) of 5,500,000 shares at $5.00 per share, with trading expected to begin on July 2, 2025 [1] - The offering is projected to generate gross proceeds of approximately $27.5 million before deducting underwriting discounts and commissions [2] - The company has granted underwriters a 30-day option to purchase an additional 825,000 shares at the IPO price [2] Company Overview - CapsoVision is a commercial-stage medical technology company focused on advanced imaging and AI technologies for capsule endoscopy solutions [1][4] - The flagship product, CapsoCam Plus®, is a wire-free capsule endoscope that provides high-resolution visualization of the small bowel [4] - The upcoming product, CapsoCam Colon, aims to facilitate non-invasive colon imaging and polyp detection, with plans to expand across various gastrointestinal indications [4]
CapsoVision Announces Pricing of Initial Public Offering
Globenewswire·2025-07-02 01:08